14159 capital (GP), LLC Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP
Get free email notifications about insider trading for 14159 capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 14159 capital (GP), LLC. 14159 capital (GP), LLC is Director in INCYTE CORP ($INCY) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
14159 capital (GP), LLC in SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: Director
Holdings: 135,739 shares
Latest Transaction: Jan 09 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of 14159 capital (GP), LLC in SYNAGEVA BIOPHARMA CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, IBPI, AUXL, GHDX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 09 2012 | GEVA | SYNAGEVA BIOPHARMA ... | 14159 capital (GP), LLC | Director | Grant | A | 25.18 | 29,089 | 732,461 | 135,739 | 106.7 K to 135.7 K (+27.28 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | 14159 capital (GP), LLC | Director | Grant | A | 0.00 | 90,457 | 0 | 106,650 | 16.2 K to 106.7 K (+558.62 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | 14159 capital (GP), LLC | Director | Grant | A | 0.00 | 8,185 | 0 | 16,193 | 8 K to 16.2 K (+102.21 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | 14159 capital (GP), LLC | Director | Grant | A | 0.00 | 7,932 | 0 | 8,008 | 76 to 8 K (+10,436.84 %) |
Page: 1